Search

Search Constraints

You searched for: Author/Creator Sillevis Smitt, Peter A E

Search Results

2. Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes. Issue 1 (28th September 2021)

3. Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes. Issue 1 (28th September 2021)

4. Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes. Issue 1 (28th September 2021)

5. Phase II trial of natalizumab for the treatment of anti-Hu associated paraneoplastic neurological syndromes. Issue 1 (28th September 2021)

6. Predictive value of electroencephalography in anti-NMDA receptor encephalitis. Issue 10 (22nd August 2018)